CCN5/WISP2 limits adipocyte differentiation in abdominal subcutaneous adipose tissue; reduced expression is linked to adipose hypertrophy associated with metabolic syndrome, while overexpression increases insulin sensitivity and is protective against metabolic syndrome [57]. This evidence concerns the gene CCN5 and metabolic syndrome.